Interroll Holding AG (0QN2)
London Exchange · UK · prices in GBP · close of 23 Oct 2026
Key indicators
| Last close | GBP 1,377.00 |
|---|---|
| 52-week range | 1,262.00 – 2,550.00 |
| Return, 1 month / 3 months | −5.0% / +5.1% |
| Return, 1 year / 3 years | −42.8% / −40.2% |
| Trend | Below its 200-day average |
| RSI (14) | 46 |
| Volatility (1 year) | 35.7% |
| Worst drawdown (1 year) | -49.9% |
| Average daily value traded | 0.79M GBP |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Interroll Holding AG supplies components and modules for internal logistics and material handling. The company makes conveyor rollers, drum motors, belt conveyors and sortation equipment used to move goods inside warehouses, distribution centres and factories. Its customers include parcel and postal operators, airports handling baggage, and manufacturers and retailers that automate the flow of goods. Interroll is based in Switzerland and serves markets around the world through its own subsidiaries and partners.
On this site Interroll Holding AG appears as a stock on the London Exchange (UK), code 0QN2, with prices in pounds sterling (GBP). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Interroll Holding AG (0QN2) trades on the London Exchange in UK. It last closed at GBP 1,377.00 on 23 October 2026.
Its price-based Market X-Ray is 33 out of 100 (a weak price profile), ranking 2,963 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 42.8% and over the last three months it rose 5.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 20 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -13.5% | ||
| From 52-week high | -45.9% | ||
| Momentum | 34 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 5.1% | ||
| 6-month return | -17.5% | ||
| 12-month return, skipping the last month | -39.7% | ||
| Stability (higher is calmer) | 35 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 35.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -49.9% | ||
| Liquidity | 51 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.79M GBP | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −3.7% |
|---|---|
| 1 month | −5.0% |
| 3 months | +5.1% |
| 6 months | −17.5% |
| 1 year | −42.8% |
| 3 years | −40.2% |
| 5 years | −70.0% |
Signals
| 50-day / 200-day average | 1,456.70 / 1,591.63 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 36.21 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 16 Jun 2026 | GBX 0.3200 |
| 11 Jun 2025 | GBX 0.3200 |
| 7 May 2024 | GBX 0.3200 |
| 16 May 2023 | GBX 0.3200 |
| 17 May 2022 | GBX 0.3100 |
| 11 May 2021 | GBX 0.2700 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.